Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Indian Drugs is Scopus-indexed (Q4, CiteScore 0.6). Published by Indian Drug Manufacturers' Association.
Checked against the index lists dated .
ISSN 0019-462XVerify ISSN ↗
Publisher: Indian Drug Manufacturers' Association
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 159 / 191 | 17th | Q4 |
| Pharmacology | 290 / 328 | 11th | Q4 |
| Drug Discovery | 151 / 161 | 6th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1989–present, best quartile Q4, CiteScore 0.6.
Indian Drugs is Q4 in Pharmaceutical Science (rank 159 of 191), Q4 in Pharmacology (rank 290 of 328) and Q4 in Drug Discovery (rank 151 of 161), by CiteScore 2025.
Indian Drugs is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q4, 17th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.146, quartile Q4, with an H-index of 33.
Indian Drugs is published by Indian Drug Manufacturers' Association. Its ISSN is 0019-462X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Indian Drugs has an h-index of 16 and a 2-year mean of 0.37 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #141 of 177 Scopus journals in Pharmaceutical Science.
Indian Drugs published 107 papers in 2025; its busiest recent year was 2021 with 142. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 29 research articles (2026), authors are most often from India (91.4%), Vietnam (3.4%) and China (1.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.